RESMED INC — Director's Dealing 2017

Apr 25, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2017-04-24

Reporting Person: ROBERTS CHRISTOPHER G (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-04-24	ResMed Common Stock	M	24390	$33.70	Acquired	170000	Direct
2017-04-24	ResMed Common Stock	M	28403	$27.58	Acquired	198403	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-04-24	ResMed Common Stock Options	$33.70	M	24390	Disposed	2017-11-11	ResMed Common Stock (24390)	Direct
2017-04-24	ResMed Common Stock Options	$27.58	M	28403	Disposed	2018-11-11	ResMed Common Stock (28403)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
ResMed Common Stock	298900	Indirect
ResMed Common Stock	136000	Indirect
ResMed Common Stock	23200	Indirect

Footnotes

F1: Transaction approved to exercise options and hold shares acquired through purchase.

F2: Options vest in full on (i) the first November 11 following the grant date, or (ii) the first annual shareholder's meeting following grant date.